Hailey is currently an Engineering Specialist at the American Institute of Chemical Engineers and works primarily with the Society for Biological Engineering, and the Center for Innovation, and Entrepreneuring Excellence. She graduated from the University of Delaware in 2017 with a Bachelors in Biomedical Engineering. During her undergraduate career, she was an undergraduate researcher in a nanomedicine lab, and interned at LafargeHolcim as an environmental compliance intern (2014-2016). After graduation, she worked as an associate scientist in an immunobioanalysis laboratory at Quest Pharmaceutical Services (QPS) in their translational medicine department.
Hear from the 2019 James E. Bailey Award winner about his research that seeks to understand the systems biology of metabolism.
Hear from UC Berkeley's Dr. Douglas S. Clark about his work which aims to teach old enzymes new tricks.
Hear from James about promising career paths in cell-free systems, and get a preview of his upcoming talk at the Cell Free Systems Conference.
Learn how numerous fields are coming together in pursuit of regenerative engineering solutions, and understand the field's special challenges.
Twist Bioscience CEO, cofounder, and director Emily Leproust discusses the company's work and the promising future of synthetic biology.
Chang Liu of UC Irvine shares his views on the the top trends in synthetic biology and tells us about his upcoming talk at SEED.
Entrepreneur Henry Uyeme discusses how he got his start and how his company, Intrida, helps various industries develop innovative intelligent data integration solutions.
Ginkgo Bioworks cofounder Reshma Shetty discusses her upcoming keynote on biological design at SEED 2019.
Caltech's Mikhail Shapiro discusses his work in cell-based medicine and highlights top trends in biomedicine.
The task of building a successful chemical startup is a marathon, not a sprint. Judy Giordan shares some advice for startup success and shares a preview of her upcoming talk on the subject.
Chemical industry entrepreneur John Sofranko talks about his background, building a business, and about his company's goals and challenges.
Jack Szostak shares his hopes for what synthetic biology can accomplish and what attendees can expect from the rich conversation about synthetic biology at the SEED conference.
Angel investor Wayne Tamarelli discusses trends for chemical startups and what you can expect form the Chemical Ventures Conference.
The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.